Rayaldee FDA approval date

The FDA approved Rayaldee (CTAP101 Capsule) on 17 Jun 2016.

FDA approval date
17 Jun 2016

Drug identity checked against registry records

Also recorded as CTAP101 Capsule

Included trials

TrialSponsorPhaseStatusPrimary completion
Safety and Efficacy of Rayaldee for Treating Mild to Moderate COVID-19NCT04551911OPKPhase 2Completed2021-10-08Actual

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2016-06-17DayRayaldeeFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA208010", "applicant_as_listed_by_fda": "EIRGEN", "brand_names": ["RAYALDEE"], "active_ingredients": ["CALCIFEDIOL"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20160617", "matched_on": "drug name equals FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026